Urologix, Inc.
Urologix, Inc. (ULGX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ulgx · pe ratio · data through Jun 30, 2014
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Urologix, Inc. (ULGX) measures how much investors pay for each dollar of the company's trailing earnings. ULGX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.36.
Source: FMP · /ratios-ttm · /analyst-estimates · 2014-06-30
PE Ratio History
1995 – 2014 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%22.0x
MedianQ3 · 75%336.8x
Max
At N/A, ULGX's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Urologix, Inc.You ULGX | $0M | N/A | — | -$0.36 |
 Anthera Pharmaceuticals, Inc. ANTH | $0M | N/A | — | -$1.65 |
 CanaQuest Medical Corp. CANQF | $0M | N/A | — | -$0.09 |
 Cotinga Pharmaceuticals Inc. COTQF | $0M | N/A | — | -$0.09 |
 ETAO International Co., Ltd. ETAOF | $0M | N/A | — | -$169.64 |
 Longport, Inc. LPTI | $0M | N/A | — | — |
 Greenwind Holdings Inc. NEWG | $0M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2014-06-30Latest FY2014 | — | $-0.36 | — | |
2013-06-30 FY2013 | — | $-0.21 | — | |
2012-06-30 FY2012 | — | $-0.32 | — | |
2011-06-30 FY2011 | — | $-0.26 | — | |
2010-06-30 FY2010 | — | $-0.15 | — | |
2009-06-30 FY2009 | — | $-0.31 | — | |
2008-06-30 FY2008 | — | $-1.04 | — | |
2007-06-30 FY2007 | — | $-0.92 | — | |
2006-06-30 FY2006 | 8.91x | $0.38 | -59.6% | |
2005-06-30 FY2005 | 22.05x | $0.20 | -93.5% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Urologix, Inc. (ULGX) measures how much investors pay for each dollar of the company's trailing earnings. ULGX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.36.
Frequently asked questions
ULGX pe ratio · 6 questionsULGX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.36. Data sourced from Financial Modeling Prep via ULGX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Urologix, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09